By comparing the expression levels of these DEGs among patients with different TNM stages, we found that CCNA2, CCNB1, CCNE1, and CCNF had particularly higher expression in patients with stage I colon cancer than in those with the advanced stage, implying that they are suitable for the diagnosis of early stage colon cancer. Here, CCNA2 is linked to malignant colon neoplasm.